166 related articles for article (PubMed ID: 38085045)
41. Indocyanine green-guided sentinel lymph node mapping during laparoscopic surgery with vaginal cuff closure but no uterine manipulator for cervical cancer.
Aoki Y; Kanao H; Fusegi A; Omi M; Okamoto S; Tanigawa T; Nomura H; Omatsu K; Tonooka A
Int J Clin Oncol; 2022 Sep; 27(9):1499-1506. PubMed ID: 35705758
[TBL] [Abstract][Full Text] [Related]
42. Laparoscopic Minimally Invasive Approach to Sentinel Lymph Node Mapping of the Ovary Using the Near-infrared Fluorescent S1 HD Pinpoint System with Indocyanine Green Dye.
Buda A; Passoni P; Reato C; Di Martino G
J Minim Invasive Gynecol; 2018 Feb; 25(2):336-337. PubMed ID: 28760628
[TBL] [Abstract][Full Text] [Related]
43. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
Crivellaro C; Landoni C; Elisei F; Buda A; Bonacina M; Grassi T; Monaco L; Giuliani D; Gotuzzo I; Magni S; Di Martino G; Delle Marchette M; Guerra L; Landoni F; Fruscio R; Messa C; De Bernardi E
Int J Gynecol Cancer; 2020 Mar; 30(3):378-382. PubMed ID: 32079712
[TBL] [Abstract][Full Text] [Related]
44. Mapping sentinel lymph nodes in early-stage ovarian cancer (MELISA) trial - a further step towards lymphadenectomy replacement.
Agustí N; Vidal-Sicart S; Paredes P; Celada-Castro C; Migliorelli F; Glickman A; Marina T; Fusté P; Carreras-Dieguez N; Saco A; Díaz-Feijóo B; Torné A
Gynecol Oncol; 2023 Dec; 179():145-151. PubMed ID: 37980769
[TBL] [Abstract][Full Text] [Related]
45. Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study.
Bjørnholt SM; Mogensen O; Bouchelouche K; Sponholtz SE; Parner ET; Hildebrandt MG; Loft A; Neumann G; Bjørn SF; Dahl K; Markauskas A; Frøding LP; Jensen PT
Gynecol Oncol; 2024 Mar; 182():179-187. PubMed ID: 38335900
[TBL] [Abstract][Full Text] [Related]
46. Surgical technique of two-step pelvic and para-aortic sentinel lymph node mapping in early-stage endometrial cancer: laparoscopic, robotic, and open method.
Cho YJ; Park JY
J Gynecol Oncol; 2023 Sep; 34(5):e67. PubMed ID: 37170729
[TBL] [Abstract][Full Text] [Related]
47. Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes.
Casarin J; Multinu F; Tortorella L; Cappuccio S; Weaver AL; Ghezzi F; Cilby W; Kumar A; Langstraat C; Glaser G; Mariani A
Int J Gynecol Cancer; 2020 Jan; 30(1):41-47. PubMed ID: 31780567
[TBL] [Abstract][Full Text] [Related]
48. Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial (KGOG2029/SELYE).
Park JY; Kim JH; Baek MH; Park E; Kim SW
J Gynecol Oncol; 2022 Nov; 33(6):e73. PubMed ID: 36047376
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic accuracy of sentinel node biopsy in non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A Turkish gynecologic oncology group study (TRSGO-SLN-006).
Altın D; Taşkın S; Ortaç F; Tokgözoğlu N; Vatansever D; Güler AH; Güngör M; Taşçı T; Beşe T; Turan H; Kahramanoğlu İ; Yalçın İ; Çelik Ç; Demirkıran F; Köse F; Arvas M; Ayhan A; Taşkıran Ç
Gynecol Oncol; 2022 Mar; 164(3):492-497. PubMed ID: 35033380
[TBL] [Abstract][Full Text] [Related]
50. FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?
Papadia A; Gasparri ML; Siegenthaler F; Imboden S; Mohr S; Mueller MD
J Cancer Res Clin Oncol; 2017 Mar; 143(3):491-497. PubMed ID: 27834005
[TBL] [Abstract][Full Text] [Related]
51. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.
Soliman PT; Westin SN; Dioun S; Sun CC; Euscher E; Munsell MF; Fleming ND; Levenback C; Frumovitz M; Ramirez PT; Lu KH
Gynecol Oncol; 2017 Aug; 146(2):234-239. PubMed ID: 28528918
[TBL] [Abstract][Full Text] [Related]
52. Sentinel lymph node mapping in endometrial cancer: A comparison of main national and international guidelines.
Dick A; Perri T; Kogan L; Brandt B; Meyer R; Levin G
Int J Gynaecol Obstet; 2023 Jan; 160(1):220-225. PubMed ID: 35700068
[TBL] [Abstract][Full Text] [Related]
53. Sentinel Lymph Node Biopsy in Surgical Staging for High-Risk Groups of Endometrial Carcinoma Patients.
Raffone A; Raimondo D; Travaglino A; Rovero G; Maletta M; Raimondo I; Petrillo M; Capobianco G; Casadio P; Seracchioli R; Mollo A
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329403
[TBL] [Abstract][Full Text] [Related]
54. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
El-Agwany AS; Meleis MH
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
[TBL] [Abstract][Full Text] [Related]
55. Prospective study of sentinel lymph node mapping for endometrial cancer.
Togami S; Kawamura T; Fukuda M; Yanazume S; Kamio M; Kobayashi H
Int J Gynaecol Obstet; 2018 Dec; 143(3):313-318. PubMed ID: 30125949
[TBL] [Abstract][Full Text] [Related]
56. Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure.
Stephens AJ; Kennard JA; Fitzsimmons CK; Manyam M; Kendrick JE; Singh C; McKenzie ND; Ahmad S; Holloway RW
Int J Gynecol Cancer; 2020 Mar; 30(3):305-310. PubMed ID: 31857439
[TBL] [Abstract][Full Text] [Related]
57. The efficiency of a combined injection technique for sentinel lymph node mapping in intermediate-high-risk endometrial cancer.
Wang Q; Wang B; Wang L; Xue Y; Shan W; Luo X; Wang C; Chen X
J Surg Oncol; 2021 Dec; 124(8):1551-1560. PubMed ID: 34496048
[TBL] [Abstract][Full Text] [Related]
58. Risk factors for failure of sentinel lymph node mapping using indocyanine green/near-infrared fluorescent imaging in endometrial cancer.
Taşkın S; Sarı ME; Altın D; Ersöz CC; Gökçe A; Yüksel S; Kankaya D; Ortaç F
Arch Gynecol Obstet; 2019 Jun; 299(6):1667-1672. PubMed ID: 30927059
[TBL] [Abstract][Full Text] [Related]
59. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis.
Bodurtha Smith AJ; Fader AN; Tanner EJ
Am J Obstet Gynecol; 2017 May; 216(5):459-476.e10. PubMed ID: 27871836
[TBL] [Abstract][Full Text] [Related]
60. Morbid obesity increases the failure rate of sentinel lymph node mapping for endometrial carcinoma.
Johnson L; Cunningham MJ
J Robot Surg; 2023 Oct; 17(5):2047-2052. PubMed ID: 37148435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
